Joel E. Tepper

MD, Radiation Oncology, UNC-Chapel Hill, Clinical Research, Gastrointestinal Oncology Program, Bone and Soft Tissue Oncology Program, Hector MacLean Distinguished Professorship in Cancer Research

MD
Hector MacLean Distinguished Professorship in Cancer Research
Radiation Oncology
UNC-Chapel Hill
Clinical Research
Gastrointestinal Oncology Program
Bone and Soft Tissue Oncology Program

Area of interest

I am in involved in clinical and translational research, primarily in gastrointestinal cancers and also in nanotechnology. I work with laboratory scientists to help advance clinical research and bring new ideas from the laboratory to clinical fruition. I have been interested in radiation sensitizers in the treatment of rectal cancer as well as combined modality therapy for many diseases in the GI track.

Awards and Honors

  • Gold Medal- American Society for Therapeutic Radiology
  • American Society of Clinical Oncology – Board of Directors
  • UNC- Berryhill Lecturer
  • Past-President and Past-Chairman of the Board- American Society for Therapeutic Radiology and Oncology (ASTRO)
  • Gold Medal- ASTRO
  • Steering Committee- ASCO/ASTRO/AGA/SSO GI Oncology Conference
  • Principle Investigator- UNC GI SPORE (Specialized Program of Research Excellence)
  • Course co-Director- AACR/ASCO Vail Workshop on Clinical Trials
  • Co-chair- US GI Intergroup (GI Steering Comm)
  • Co-PI on a GI Intergroup trial of adjuvant chemoradiation therapy in gastric cancer
  • Paper demonstrating the value of surgical salvage in rectal cancer in a large Intergroup clinical trial cohort- to be published in the Journal of Clinical Oncology
  • Demonstration of the importance of substaging of rectal cancer for individualization of adjuvant therapy
  • Early phase studies defining the ability to combine various agents (farnesyl transferase inhibitors, gemcitabine, oxaliplatin) with radiation therapy in various tumor types
  • Design of new radiation parameters for adjuvant treatment of gastric cancer and its implementation in the new Intergroup gastric adjuvant trial

Reach NC Profile

Find publications on Pubmed